Who
Mark Alvino
Director
Company insider
Files Form 4 as: Director, Abeona Therapeutics; Director, Macrochem.
In numbers
- Trades disclosed
- 44
- Buys
- 0
- Sells
- 16
- Bought
- $0
- Sold
- $845K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 6 Dec 2006
- Last trade
- 1 Sep 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 1 Sep 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $88K15,000 at $5.86 | filing |
| 1 Sep 2026filed 1 Sep 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $88K15,000 at $5.86 | filing |
| 26 May 2026filed 26 May 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code G | —500 at $0.00 | filing |
| 26 May 2026filed 26 May 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code G | —500 at $0.00 | filing |
| 22 May 2026filed 22 May 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $35K6,500 at $5.46 | filing |
| 22 May 2026filed 22 May 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $35K6,500 at $5.46 | filing |
| 2 Feb 2026filed 2 Feb 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $10K2,000 at $5.09 | filing |
| 2 Feb 2026filed 2 Feb 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $10K2,000 at $5.09 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 21 Jan 2026filed 21 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $71K13,500 at $5.23 | filing |
| 21 Jan 2026filed 21 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $71K13,500 at $5.23 | filing |
| 13 Nov 2025filed 14 Nov 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $71K15,000 at $4.74 | filing |
| 9 Jul 2025filed 10 Jul 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $77K13,093 at $5.86 | filing |
| 27 May 2025filed 27 May 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $13K2,000 at $6.38 | filing |
| 16 May 2025filed 16 May 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $45K8,000 at $5.68 | filing |
| 31 Jan 2025filed 3 Feb 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —36,101 at $0.00 | filing |
| 29 Jan 2025filed 31 Jan 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $22K4,000 at $5.38 | filing |
| 21 Jan 2025filed 21 Jan 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $20K4,000 at $5.10 | filing |
| 26 Aug 2024filed 27 Aug 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —11,797 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.